Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Vaccine Response in People Living With Sickle Cell Disease

NCT05139992 is registered in ClinicalTrials.gov with ASH Research Collaborative as lead sponsor.

NCT NCT05139992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Vaccine Response in People Living With Sickle Cell Disease
Lead sponsor
ASH Research Collaborative
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
December 31, 2023
Enrollment
59 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sickle cell disease